{"id":77116,"date":"2021-02-06T21:57:00","date_gmt":"2021-02-06T13:57:00","guid":{"rendered":"https:\/\/www.chinapulse.com\/?p=170982"},"modified":"2021-02-06T21:57:00","modified_gmt":"2021-02-06T13:57:00","slug":"china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use","status":"publish","type":"post","link":"https:\/\/www.chinalegalblog.com\/en\/2021\/02\/06\/china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use\/","title":{"rendered":"China approves Sinovac Biotech COVID-19 vaccine for general public use"},"content":{"rendered":"<p>China approves Sinovac Biotech COVID-19 vaccine for general public use Feb 6, 2021 &#124; World<\/p>\n<p>BEIJING (Reuters) \u2013 Sinovac Biotech said on Saturday that its unit\u2019s COVID-19 vaccine has been approved for use by the general public by China\u2019s medical products regulator.&#8230;<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/www.chinapulse.com\/data-news\/2021\/02\/06\/china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use\/\">China approves Sinovac Biotech COVID-19 vaccine for general public use<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/www.chinapulse.com\/\">ChinaPulse.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>China approves Sinovac Biotech COVID-19 vaccine for general public use Feb 6, 2021 &#124; World<br \/>\nBEIJING (Reuters) \u2013 Sinovac Biotech said on Saturday that its unit\u2019s COVID-19 vaccine has been approved for use by the general public by China\u2019s medical pro&#8230;<\/p>\n","protected":false},"author":250,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65,144,213,1607,288,194,494,1542,296],"tags":[7582,2636,10324,2214,3900,2240,10400,7035],"class_list":["post-77116","post","type-post","status-publish","format-standard","hentry","category-beijing","category-china","category-china-news","category-manufacturing","category-medicine","category-news-chinese-law","category-pharmaceutical","category-technology","category-world-health-organization","tag-biotech","tag-brazil","tag-covid-19","tag-indonesia","tag-laos","tag-military","tag-turkey","tag-vaccine"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/77116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/250"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=77116"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/77116\/revisions"}],"predecessor-version":[{"id":77117,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/77116\/revisions\/77117"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=77116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=77116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=77116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}